IGF2BP3 mutation resulted in the loss of its function in the activation of oncogenic PI3K and MAPK signalling pathways, including mitophagy, which resulted in the inhibition of cervical cancer cell growth and tumourigenesis. The gene discussed is IGF2BP3; the disease is cervical carcinoma.